Hartford and New Haven were ranked among the top places to live in the United States for 2022-2023, according to a report released in May by U.S News & World Report.

The report examined 150 different cities that are given a score out of 10 based on their desirability, value, the job market, quality of life and net migration, which measures whether people are moving to or away from each metro area.

New Haven was ranked as No. 114 with an overall score of 6. The report highlights features like its pizzerias, college sports and food trucks. New Haven has an average housing cost of $376,708 and residents have an average salary of $61,990, the report indicates. Read More

New Haven hotels are roaring back from the dark days of the pandemic, largely thanks to pent-up demand in leisure travel.

“We’re hopping,” says Dana Zimmerman, director of sales and marketing at the Omni New Haven at Yale, as she scrambled to accommodate the annual rush of Yale’s commencement weekend.

But the comeback is uneven, cautions Ginny Kozlowski, executive director of the Connecticut Lodging Association.

In March, the latest numbers available, Connecticut’s 40,000 hotel rooms were 55% booked at an average rate of $117.41. That’s a marked improvement from the past two years and is comparable to 2019. Read More

6/22 9 a.m.-2 p.m. Boston, MA

The SME Dialogue is a FREE event convened by the Office of the U.S. Trade Representative, the U.S. Department of Commerce, and the U.S. Small Business Administration with the UK Department for International Trade, and the UK Department for Business, Energy and Industrial Strategy.

Topics for discussion include an update on U.S.-UK trade; opportunities for U.S.-UK SME trade and cooperation in emerging technologies; global expansion best practices for U.S. and UK companies; access to capital for SME global expansion; and trade resources for small businesses. Attendees will be able to engage in discussion with experts as well as learn about tools and resources to grow their businesses internationally. Read More

One sign that New Haven's bioscience cluster is thriving is what's been happening when companies are bought out – their local facilities and workforce are staying put.

When pharma giant Pfizer announced it would buy Biohaven for $11.6 billion in May, it said it would keep the drug company’s New Haven operations running. AstraZeneca not only kept the Elm City research labs of Alexion open after its $39 billion buyout, it is adding new staff at a steady pace and planning a major expansion into the new 101 College St. bioscience tower.

“We're doing really well in having acquisitions happen and not having the companies be folded,” said Dawn Hocevar, president and CEO of industry group BioCT. She also cited earlier examples of the trend in the region, with Sanofi continuing operations at Protein Sciences in Meriden and Lilly keeping Loxo Oncology open in Stamford. Read More